48,874
edits
Difference between revisions of "Talk:Programmed death-ligand 1"
Jump to navigation
Jump to search
Talk:Programmed death-ligand 1 (view source)
Revision as of 13:14, 17 February 2018
, 13:14, 17 February 2018no edit summary
| Line 7: | Line 7: | ||
*2018 paper: ~ 70% durable response among those that discontinue d/t side effects[https://www.ncbi.nlm.nih.gov/pubmed/29437040] | *2018 paper: ~ 70% durable response among those that discontinue d/t side effects[https://www.ncbi.nlm.nih.gov/pubmed/29437040] | ||
*2018 paper: response rates are low in UCC and RCC, current PD-L1 tests not useful in UCC and RCC[https://www.ncbi.nlm.nih.gov/pubmed/29368638] | *2018 paper: response rates are low in UCC and RCC, current PD-L1 tests not useful in UCC and RCC[https://www.ncbi.nlm.nih.gov/pubmed/29368638] | ||
==References== | |||
{{Reflist|1}} | |||